Product nameFlunixin meglumin, Cyclooxygenase inhibitor
DescriptionCyclooxygenase inhibitor used as an analgesic agent with anti-inflammatory and antipyretic activity
- 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylate, 1-deoxy-1-(methylamino)-D-glucitol(1:1)
Non-narcotic, non-steroidal anti-inflammatory drug (NSAID) used as an analgesic agent with antipyretic activities. Cyclooxygenase (COX) inhibitor. Used in animals for the management of intestinal ischaemia, colic, and endotoxemia.
Storage instructionsStore at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.
Solubility overviewSoluble in DMSO to 100 mM, in water to 100 mM and in ethanol to 10 mM
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Toxic, refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
This product has been referenced in:
- Avila TV et al. Hepatic effects of flunixin-meglumin in LPS-induced sepsis. Fundam Clin Pharmacol 24:759-69 (2010). Read more (PubMed: 20030736) »
- Bryant CE et al. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. Am J Vet Res 64:211-5 (2003). Read more (PubMed: 12602591) »
- Miyazaki Y et al. Possible active transport mechanism in pharmacokinetics of flunixin-meglumin in rabbits. J Vet Med Sci 63:885-8 (2001). Read more (PubMed: 11558544) »